Auto1-MS1

Obe-cel in Refractory Progressive Forms of Multiple Sclerosis

Condition(s)

  • Multiple sclerosis

Project type

  • Clinical drug trial

About the project

This phase 1 clinical trial is designed to establish the tolerability, safety, and preliminary efficacy of obe-cel in participants with refractory progressive multiple sclerosis.  

Funder(s)

Autolus Limited UK
The logo for Autolus for the Auto1-MS1 clinical trial

Status

Closed for recruitment at this site

Contact

Jill Hunter, Senior Research Nurse

Anne.Rowling.Clinic@ed.ac.uk

0131 465 9517

Eligibility criteria

Complex eligibility criteria apply, please get in touch for more details.

×